Literature DB >> 20220125

After half a century of research on smoking and PD, where do we go now?

Beate Ritz, Shannon L Rhodes.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20220125     DOI: 10.1212/WNL.0b013e3181d63aa8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  13 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  Focus on α4β2* and α6β2* nAChRs for Parkinson's Disease Therapeutics.

Authors:  Xiomara A Pérez; Maryka Quik
Journal:  Mol Cell Pharmacol       Date:  2011

3.  In search of the causes of Parkinson's disease, seasons 1 to 4.

Authors:  Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-05-31       Impact factor: 8.082

4.  Smoking cessation for the neurologic patient.

Authors:  Jinny Tavee
Journal:  Neurol Clin Pract       Date:  2012-06

5.  Smoking and Parkinson disease: Evidence for gene-by-smoking interactions.

Authors:  Pei-Chen Lee; Ismaïl Ahmed; Marie-Anne Loriot; Claire Mulot; Kimberly C Paul; Jeff M Bronstein; Beate Ritz; Alexis Elbaz
Journal:  Neurology       Date:  2018-01-19       Impact factor: 9.910

6.  Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease.

Authors:  Cloé Domenighetti; Pierre-Emmanuel Sugier; Ashwin Ashok Kumar Sreelatha; Claudia Schulte; Sandeep Grover; Océane Mohamed; Berta Portugal; Patrick May; Dheeraj R Bobbili; Milena Radivojkov-Blagojevic; Peter Lichtner; Andrew B Singleton; Dena G Hernandez; Connor Edsall; George D Mellick; Alexander Zimprich; Walter Pirker; Ekaterina Rogaeva; Anthony E Lang; Sulev Koks; Pille Taba; Suzanne Lesage; Alexis Brice; Jean-Christophe Corvol; Marie-Christine Chartier-Harlin; Eugénie Mutez; Kathrin Brockmann; Angela B Deutschländer; Georges M Hadjigeorgiou; Efthimos Dardiotis; Leonidas Stefanis; Athina Maria Simitsi; Enza Maria Valente; Simona Petrucci; Stefano Duga; Letizia Straniero; Anna Zecchinelli; Gianni Pezzoli; Laura Brighina; Carlo Ferrarese; Grazia Annesi; Andrea Quattrone; Monica Gagliardi; Hirotaka Matsuo; Yusuke Kawamura; Nobutaka Hattori; Kenya Nishioka; Sun Ju Chung; Yun Joong Kim; Pierre Kolber; Bart Pc van de Warrenburg; Bastiaan R Bloem; Jan Aasly; Mathias Toft; Lasse Pihlstrøm; Leonor Correia Guedes; Joaquim J Ferreira; Soraya Bardien; Jonathan Carr; Eduardo Tolosa; Mario Ezquerra; Pau Pastor; Monica Diez-Fairen; Karin Wirdefeldt; Nancy L Pedersen; Caroline Ran; Andrea C Belin; Andreas Puschmann; Clara Hellberg; Carl E Clarke; Karen E Morrison; Manuela Tan; Dimitri Krainc; Lena F Burbulla; Matt J Farrer; Rejko Krüger; Thomas Gasser; Manu Sharma; Alexis Elbaz
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 7.  Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses.

Authors:  Honglei Chen; Keran Wang; Filip Scheperjans; Bryan Killinger
Journal:  Neurobiol Dis       Date:  2021-12-23       Impact factor: 7.046

8.  Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.

Authors:  Michael G Schlossmacher; Julianna J Tomlinson; Goncalo Santos; Bojan Shutinoski; Earl G Brown; Douglas Manuel; Tiago Mestre
Journal:  Eur J Neurosci       Date:  2016-12-27       Impact factor: 3.386

9.  Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis.

Authors:  Frédéric Moisan; Sofiane Kab; Fatima Mohamed; Marianne Canonico; Morgane Le Guern; Cécile Quintin; Laure Carcaillon; Javier Nicolau; Nicolas Duport; Archana Singh-Manoux; Marjorie Boussac-Zarebska; Alexis Elbaz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-12-23       Impact factor: 10.154

Review 10.  The Changing Landscape of Parkinson Epidemiologic Research.

Authors:  Honglei Chen
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.